Dyne Therapeutics Announces Pricing of Upsized $375 Million Public Offering of Common Stock
Dyne Therapeutics priced an upsized underwritten public offering of 18.3 million shares at $20.50 per share, expecting to generate approximately $375.15 million in gross proceeds. All shares are being sold by the company, with the offering anticipated to close on or about July 23, 2026.
Key figures
- Deal Value Usd
- 375150000
- Offering Price
- 20.5
- Shares Offered
- 18300000
- Greenshoe shares
- 2745000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.